Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Rodgers

Showing results (211-220 of 356) with videos related to

Pageof 36
Sort By:
Diabetes Care|July 27, 2016
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 DiabetesKamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, et al.
Journal of Psychopharmacology (Oxford, England)|February 19, 2019
A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trialVerónica Gálvez Ortiz, Paul Glue, Andrew A Somogyi, et al.
Nutrition & Diabetes|January 19, 2018
Associations between body mass index and the risk of renal events in patients with type 2 diabetesKamel Mohammedi, John Chalmers, William Herrington, et al.
Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.
Lancet (London, England)|March 7, 2003
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease riskChristopher J L Murray, Jeremy A Lauer, Raymond C W Hutubessy, et al.
Addiction (Abingdon, England)|June 10, 2010
Pre-cessation nicotine replacement therapy: pragmatic randomized trialChris Bullen, Colin Howe, Ruey-Bin Lin, et al.
Journal of Hypertension|April 22, 2021
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE TrialsNelson Wang, Katie Harris, John Chalmers, et al.
European Journal of Preventive Cardiology|April 25, 2017
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high riskMelvin Lafeber, Wilko Spiering, Frank Lj Visseren, et al.
British Journal of Clinical Pharmacology|June 8, 2022
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptionsMatthew J Coleshill, Richard O Day, Karson Tam, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2022
Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus-results from the TRIUMPH randomised controlled trialSonali R Gnanenthiran, Ruth Webster, Asita de Silva, et al.
Pageof 36

Showing results (211-220 of 356) with videos related to

Sort By:
Pageof 36
Diabetes Care|July 27, 2016
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 DiabetesKamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, et al.
Journal of Psychopharmacology (Oxford, England)|February 19, 2019
A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trialVerónica Gálvez Ortiz, Paul Glue, Andrew A Somogyi, et al.
Nutrition & Diabetes|January 19, 2018
Associations between body mass index and the risk of renal events in patients with type 2 diabetesKamel Mohammedi, John Chalmers, William Herrington, et al.
Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.
Lancet (London, England)|March 7, 2003
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease riskChristopher J L Murray, Jeremy A Lauer, Raymond C W Hutubessy, et al.
Addiction (Abingdon, England)|June 10, 2010
Pre-cessation nicotine replacement therapy: pragmatic randomized trialChris Bullen, Colin Howe, Ruey-Bin Lin, et al.
Journal of Hypertension|April 22, 2021
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE TrialsNelson Wang, Katie Harris, John Chalmers, et al.
European Journal of Preventive Cardiology|April 25, 2017
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high riskMelvin Lafeber, Wilko Spiering, Frank Lj Visseren, et al.
British Journal of Clinical Pharmacology|June 8, 2022
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptionsMatthew J Coleshill, Richard O Day, Karson Tam, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2022
Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus-results from the TRIUMPH randomised controlled trialSonali R Gnanenthiran, Ruth Webster, Asita de Silva, et al.
Pageof 36